Nordic News, Business and Life in Asia
Danish drugmaker Novo Nordisk has introduced a higher-dose version of semaglutide in Thailand, giving adults with type 2 diabetes an additional treatment option. The company announced the introduction in a …
Novo Nordisk introduces new diabetes treatment option in Thailand Read More
A new central kitchen at Wat Don School in Bangkok is set to provide healthier school meals to almost 1,500 pupils as part of a cooperation between Bangkok, Denmark and …
Novo Nordisk-backed kitchen brings healthier meals to 1,500 Bangkok pupils Read More
The Philippine Embassy in Copenhagen has brought together more than 20 Filipino scientists, researchers and students for what it described as the first gathering of its kind in Denmark. The …
First gathering connects Filipino scientists in Denmark Read More
Danish pharmaceutical company Novo Nordisk has moved a step closer to launching an oral version of its weight-loss drug Wegovy in China. China’s drug regulator has accepted the company’s application …
China accepts Novo Nordisk application for oral Wegovy Read More
The top management of Danish pharmaceutical giant Novo Nordisk reportedly travelled to China in June to explore the possibility of partnering with a local manufacturer, according to the Danish business …
Novo Nordisk explores chinese manifacturing partnership Read More
A race over obesity treatments is heating up in China, as global pharmaceutical giants compete to dominate the fast-growing market for weight-loss drugs. Danish pharmaceutical company Novo Nordisk says it …
Novo Nordisk moves to launch Wegovy tablet in China Read More
A growing obesity crisis in the Philippines is now raising concerns far beyond public health. The problem is increasingly seen as a threat to the country’s economy and workforce productivity, …
Danish pharma giant steps up obesity campaign in the Philippines Read More
Danish pharmaceutical company Novo Nordisk said generic versions of its diabetes drug Ozempic could be delayed in China until 2027 due to regulatory data protection rights. The patent for semaglutide, …
Novo Nordisk says Ozempic copycats in China may be delayed Read More Novo Nordisk has entered a strategic partnership with OpenAI to boost drug discovery and development, R&D World reports. The collaboration will allow Novo Nordisk to analyse massive datasets at a …
Novo Nordisk expands in China while betting on AI Read More The Danish pharmaceutical giant Novo Nordisk has reported encouraging results from a new diabetes and weight loss drug developed with a Chinese partner, Fierce Biotech reports. The candidate, known as …
Novo Nordisk tests China-developed drug for obesity and diabetes while competition is growing Read More
Novo Nordisk will lose patent protection for its blockbuster drug Ozempic in several major markets from Saturday. The patent expiry opens the door for other manufacturers to produce cheaper generic …
Novo Nordisk will lose patent protection on Saturday Read More Novo Nordisk and China’s United Laboratories International Holdings have announced promising results from a clinical trial of a new experimental obesity drug, the company reports in a press release. In …
Novo and Chinese partner report strong weight loss results Read More
A Chinese biotechnology company, Shanghai Shiling Pharmaceutical, plans to complete clinical trials by 2028 for a weight-loss nasal spray that uses semaglutide, the same active ingredient as Danish drugmaker Novo Nordisk’s …
Chinese biotech develops semaglutide spray as Novo Nordisk patent expires in China Read More
The Bangkok Metropolitan Administration (BMA), the Royal Danish Embassy in Bangkok and Novo Nordisk Pharma Thailand have signed a Memorandum of Understanding to establish “Bangkok, City for Better Health”, a …
Bangkok–Denmark health partnership launches ‘City for Better Health’ initiative Read More
Bangkok has joined forces with Denmark to promote healthier living and combat obesity through a new initiative titled “Bangkok, City for Better Health.” The programme follows a Memorandum of Understanding …
Bangkok launches Danish-backed health initiative to fight obesity Read More
Chonburi Hospital and Novo Nordisk Pharma (Thailand) Ltd. held the “Unlock and Rock Haemophilia” event on 20 October 2025 in Chonburi to raise awareness and improve understanding of haemophilia among …
Chonburi Hospital partners with Denmark’s Novo Nordisk Read More
The seventh China–Nordic Economic and Trade Forum will take place from 14 to 16 October in Wuhan, Hubei Province, bringing together more than 30 countries and regions alongside over 200 …
China–Nordic Economic and Trade Forum returns to Wuhan in October Read More
The Danish Embassy in Bangkok hosted a lunch with the Governor of Bangkok Mr. Chadchart Sittipunt, ambassadors, and members of the ECO-Capitals Forum to renew their pledge for sustainable development …
Danish Embassy hosts eco-forum lunch with Bangkok governor and ambassadors Read More
Siriraj Hospital and MIT Hacking Medicine have launched the second edition of their joint innovation hackathon, Siriraj × MIT Hacking Medicine 2025, set to take place in Bangkok from 31 …
Novo Nordisk among supporters of Bangkok health innovation hackathon Read More The Singapore International Commercial Court (SICC) has upheld a worldwide freeze on USD 730 million in assets owned by Singapore-based KBP Biosciences in a dispute raised by Danish pharmaceutical giant …
Singapore court upholds 730 million USD freezing order in favour of Novo Nordisk Read More
An article by Thai business platform ลงทุนแมน, recently shared by the Thai-Swedish Chamber of Commerce, sheds light on what drives the international success of Nordic companies—despite their countries’ small populations …
Why Nordic companies go global from day one Read More
Thammasat University Hospital and Novo Nordisk Pharma (Thailand) Ltd. have launched a new collaboration titled “Partnership Project for the Transition into the Fourth Decade of Thammasat University Hospital: Beat Obesity, …
Thammasat University Hospital and Novo Nordisk Thailand join forces to fight obesity and diabetes Read More
In a unique collaboration to raise awareness of haemophilia in Thailand, Danish healthcare company Novo Nordisk and Thai footwear brand Nanyang have partnered to deliver specially designed shoes to members …
Novo Nordisk and Nanyang raise haemophilia awareness in Thailand Read More
Novo Nordisk has officially launched its weight loss medication Wegovy in China. This move opens access to over 500 million potential candidates for treatment by 2045. Regulatory approval and market …
Novo Nordisk launches Wegovy in China Read More
Novo Nordisk, the Danish pharmaceutical giant renowned for its diabetes and weight-loss medications, including the blockbuster drugs Ozempic and Wegovy, announced impressive third-quarter earnings despite challenges with production constraints. Novo …
Novo Nordisk reports strong profits despite production constraints Read More
Siriraj Hospital, part of Mahidol University’s Faculty of Medicine, has signed a Memorandum of Understanding (MOU) with Novo Nordisk Pharma (Thailand) Co., Ltd. This agreement aims to advance research and …
Siriraj Hospital and Novo Nordisk partner on chronic diseases research and development Read More
The Danish pharmaceutical company Novo Nordisk has signes a deal with a Indonesian state-owned drug company called Bio Farma. Their goal is to produce insulin to fight diabetes within Indonesia. …
Novo Nordisk will help combat diabetes in Indonesia Read More
Just as Novo Nordisk’s weight loss drug Wegovy has been allowed on the Chinese market, the company’s Chinese rivals Innovent Biologics and Eli Lilly have published news about their own …
New Chinese drug can challenge Novo Nordisk’s Wegovy in China Read More
The popular weight loss medicin Wegovy by the Danish phamaceutical firm Novo Nordisk has been approved for consumers in China. This has been confirmed by an employee at the company. …
Wegovy approved in China Read More A Chinese drugmaker applied for approval on 3 April 2024 to sell their biosimilar Ozempic drug in China. This potentially challenges the expansion plans of Novo Nordisk in China, who …
Chinese drugmaker seeks approval of Ozempic-like drug Read More
The Chinese version of the Novo Nordisk Semaglutide injection Wegovy has gotten the green light to begin clinical trials for weight loss treatment. The drug is developed by CSPC Pharmaceutical …
Chinese version of Novo Nordisk drug gets green light Read More
The Danish Ambassador to the Philippines Franz-Michael Mellbin along with the Corporate VP of the Danish pharmaceutical company Novo Nordisk Anand Shetty and other officials took part in the launch …
Danish envoy participates in launch of Changing Diabetes in Children Program in PH Read More
The Danish pharmaceutical company Novo Nordisk boosts its production in China by investing around US$ 556 million in its Chinese flagship factory in Tianjin. The sterile preparation expansion project has …
Novo Nordisk boosts drug production in China Read More
The Danish healthcare company Novo Nordisk expects China to approve their popular weight-loss drug, Wegovy, for sale this year. The company will initially focus on patient paying out-of-pocket for the …
Novo Nordisk expects China to approve Wegovy Read More
The Danish Embassy in Thailand hosted an information meeting last week to prepare companies for the new rule for visa requirements for foreign workers in Denmark working for Danish companies …
The Danish Embassy in Thailand hosted info event for businesses Read More
Today it is World Diabetes Day. And lately, attention to the disease has been spread across Southeast Asia. Novo Nordisk sponsored an event in Hanoi last Saturday to spread awareness …
Novo Nordisk sponsored event in Hanoi for diabetes awareness Read More
Danish Novo Nordisk said on 10 November that it will invest more than 42 billion DKK – $6 billion USD – to expand its manufacturing facilities in Kalundborg, Denmark for …
Novo Nordisk 100th anniversary: Invests $6 billion in expansions Read More
Danish Novo Nordisk said on Monday 16 October 2023 that it will spend up to $1.3 billion to buy an experimental hypertension (high blood pressure) drug from Singapore-based ‘KBP Biosciences.’ …
Novo Nordisk buys experimental blood pressure drug from Singapore Read More Novo Nordisk has established itself in the medicine market with patents that earn billions. Mainly due to the obesity drug Wegovy and the diabetes medicine Ozempic. Both consists of an …
Approaching patent expiration in China may threaten Novo’s billion-dollar business Read More
Danish pharmaceutical company Novo Nordisk has surpassed LVMH and is now Europe’s most valuable listed company. LVMH, the world’s biggest luxury retailer, is currently suffering due to growing concerns about …
Danish Novo Nordisk surpasses LVMH as Europe’s most valuable company Read More
Danish pharmaceutical company Novo Nordisk has achieved the highest year-on-year revenue growth by sales during the second quarter of 2023 – in comparison to the other 20 top pharmaceutical firms, …
Novo Nordisk in record growth due to obesity and diabetes drug sales Read More
Foreign Minister Lars Løkke Rasmussen will travel to China on Wednesday, August 16, where he will meet with the country’s Foreign Minister Wang Yi. The three-day visit begins in Shanghai, …
The Danish Foreign Minister on diplomatic trip to China Read More
Novo Nordisk’s obesity medicine Wegovy reduces the risk of heart attacks and strokes according to a highly anticipated study. People with obesity or are overweight with a history of heart …
Novo Nordisk is now second biggest firm in Europe after study finds that Wegovy cuts risk of heart attacks Read More
The Danish drugmaker, Novo Nordisk, announced that it will invest 15.9 billion Danish crowns ($2.29 billion) to expand a new production facility in Denmark for producing chronic diseases curing products …
Novo Nordisk invests $2.3 bln to new production facility for producing chronic diseases curing products Read More
Danish pharmaceutical titan Novo Nordisk has applied to China’s drug regulator to widen the range of use of its diabetes medicine Ozempic. In the US Ozempic is also used as …
Novo Nordisk’s diet drug may land in China soon Read More
Danish Novo Nordisk reported Thursday, May 4, a 39% increase in first-quarter profits, due to the company’s sales of obesity treatments. From January to March, net profit reached 19.8 billion …
Novo Nordisk experience big profit rise due to obesity treatments Read More
Danish toymaker Lego said on Thursday, April 20, that the company has agreed to buy e-methanol for use in its colorful plastic bricks. E-methanol is a lower-carbon alternative to conventional …
Lego and Novo Nordisk agree to buy green methanol for plastic production Read More
Health Sciences Authority (HSA) in Singapore has given the green light to Wegovy. Wegovy is the weight-loss drug by Danish pharmaceutical company Novo Nordisk, that has gained huge popularity on …
Singapore approves Danish weight-loss drug Read More Novo Nordisk Pharmatech, part of the Novo Nordisk group, has purchased a 47,000 square meter site in Koge, Denmark. The goal is to expand production, the company said on Friday. …
Novo Nordisk aims to expand production Read More
Novo Nordisk’s diabetes drug Ozempic has become a social media phenomenon for its weight loss effects. Its sky-high popularity has led to global shortage and doctors warn about the potential …
Doctors worried about Danish weight loss drug trending on TikTok Read More